Paul R Skolnik
Overview
Explore the profile of Paul R Skolnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1889
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cloherty G, Swanson P, Lucic D, Dieckhaus K, Anthony P, Cataline P, et al.
J Virol Methods
. 2014 Apr;
204:91-2.
PMID: 24747107
Studies have demonstrated that plasma samples collected and stored frozen using vacutainer plasma preparation tubes (PPT) may result in falsely elevated viral load (VL) values with the Roche COBAS TaqMan...
2.
Baranoski A, Meuser E, Hardy H, Closson E, Mimiaga M, Safren S, et al.
AIDS Care
. 2013 Jun;
26(1):26-32.
PMID: 23742640
Innovative techniques, potentially using technology, to improve adherence to antiretroviral therapy (ART) may help patients with HIV who struggle with self-care. This qualitative study compared patient and provider participants' perspectives...
3.
McInnes D, Hardy H, Goetz M, Skolnik P, Brewster A, Hofmann R, et al.
J Int Assoc Provid AIDS Care
. 2012 Sep;
12(6):397-406.
PMID: 22968353
Background: HIV medication nonadherence is a major problem, yet many providers lack the time and training to carefully ask patients about their adherence. Objective: To design and pilot a technology-assisted...
4.
Gardner L, Marks G, Craw J, Wilson T, Drainoni M, Moore R, et al.
Clin Infect Dis
. 2012 Jul;
55(8):1124-34.
PMID: 22828593
Background: Retention in care for human immunodeficiency virus (HIV)-infected patients is a National HIV/AIDS Strategy priority. We hypothesized that retention could be improved with coordinated messages to encourage patients' clinic...
5.
Moore J, Hardy H, Skolnik P, Moss F
Annu Int Conf IEEE Eng Med Biol Soc
. 2012 Jan;
2011:1523-7.
PMID: 22254610
Electronic reminder systems have been available for decades, yet medication adherence remains poor. Most systems rely on simple alarms and do not address other determinants of health-related behavior. This paper...
6.
Hardy H, Kumar V, Doros G, Farmer E, Drainoni M, Rybin D, et al.
AIDS Patient Care STDS
. 2011 Feb;
25(3):153-61.
PMID: 21323532
Adherence to antiretroviral therapy (ART) represents one of the strongest predictors of progression to AIDS, yet it is difficult for most patients to sustain high levels of adherence. This study...
7.
Garg S, Hoenig M, Edwards E, Bliss C, Heeren T, Tumilty S, et al.
AIDS Patient Care STDS
. 2011 Feb;
25(3):135-41.
PMID: 21309706
Coinfection with hepatitis C (HCV) significantly increases the risk of acute and chronic renal disease in HIV-infected individuals. However, the burden of acute kidney injury (AKI) directly attributable to HIV...
8.
Pereyra F, Jia X, McLaren P, de Bakker P, Walker B, Ripke S, et al.
Science
. 2010 Nov;
330(6010):1551-7.
PMID: 21051598
Infectious and inflammatory diseases have repeatedly shown strong genetic associations within the major histocompatibility complex (MHC); however, the basis for these associations remains elusive. To define host genetic effects on...
9.
Wilkin T, Su Z, Krambrink A, Long J, Greaves W, Gross R, et al.
J Acquir Immune Defic Syndr
. 2010 Jul;
54(5):470-6.
PMID: 20672447
Background: Vicriviroc, an investigational CCR5 antagonist, demonstrated short-term safety and antiretroviral activity. Methods: Phase 2, double-blind, randomized study of vicriviroc in treatment-experienced subjects with CCR5-using HIV-1. Vicriviroc (5, 10, or...
10.
Wasan S, Skolnik P, Farraye F
Clin Gastroenterol Hepatol
. 2010 Jul;
8(12):1013-6.
PMID: 20656060
No abstract available.